Bone and musculoskeletal research: Some work has extended into bone repair and osteoporosis models, where AOD9604 has shown early signs of supporting bone remodeling, though this area is less developed than its fat metabolism and cartilage research
[15] This complex consists of the following symptoms: Impaired perception of deep touch, pressure and vibration, loss of sense of touch, very annoying and persistent paresthesias Ataxia of dorsal column type Decrease or loss of deep muscle-tendon reflexes Pathological reflexes Babinski, Rossolimo and others, also severe paresis
But that has not been established in humans, and there are very limited ongoing clinical trials to illuminate the real efficacy and safety of these peptides
That extra step can prevent confusion between micrograms, milliliters, and total vial contents
The mechanisms behind MOTS-c are fascinating, but the peptide has a notable lack of long-term safety data